Article
Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.
Immunology - 1 Oct 2017
Allison Katrina E, Coomber Brenda L, Bridle Byram W
Abstract excerpt
Altered metabolism is a hallmark of cancers, including shifting oxidative phosphorylation to glycolysis and up-regulating glutaminolysis to divert carbon sources into biosynthetic pathways that promote proliferation and survival. Therefore, metabolic inhibitors represent promising anti-cancer drugs. However, T cells must rapidly divide and survive in harsh microenvironments to mediate anti-cancer effects....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
